NCT00880009 2021-09-27Study Evaluating Bosutinib-Letrozole Combination Versus Letrozole Alone In Post Menopausal Women With Breast CancerPfizerPhase 2 Terminated16 enrolled 6 charts
NCT02906696 2020-05-11Bosutinib in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase After Frontline TKI FailureM.D. Anderson Cancer CenterPhase 2 Terminated8 enrolled 14 charts
NCT00793546 2012-11-05Study Evaluating Bosutinib-Exemestane Combination Vs Exemestane Alone in Post Menopausal Women With Breast CancerPfizerPhase 2 Terminated42 enrolled 7 charts